- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00124501
Effectiveness of Biofeedback-Assisted Relaxation Training in Children With Eosinophilic Duodenitis
May 29, 2008 updated by: Children's Mercy Hospital Kansas City
The Impact of Biofeedback-Assisted Relaxation Training on Pain and Functional Disability in Children Diagnosed With Eosinophilic Duodenitis: Pilot Study
The purpose of this study is to determine whether the addition of Biofeedback-Assisted Relaxation to standard medication treatment improves outcomes for children with a specific type of recurrent abdominal pain (i.e., eosinophilic gastroenteritis).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Recurrent abdominal pain (RAP) is the most common type of pain in school age children and young adolescents.
Previous studies suggest that stress plays an important role in the activation of specific cells that can produce pain within the stomach and intestines.
Medication is the standard approach to the treatment of RAP in children.
Although medication is helpful for many children, medication alone is not always enough.
Biofeedback trains individuals to use relaxation strategies effectively to relieve emotional and physical symptoms, and has been used successfully for stress and pain reduction with both children and adults.
It has shown promising results when used alone in the treatment of children with RAP.
Research is needed, however, to determine whether biofeedback training is helpful when used in conjunction with medication.
Information about how biofeedback training affects the central nervous system and the cells that produce pain also would be useful in refining treatments for this large group of children.
The current research will be done in three steps, with Phase 1 designed to evaluate the time, resources, technical support, and sample size needed for successful completion of the full research study.
Twenty children (ages 8-18) with eosinophilic duodenitis, a specific form of RAP, will be enrolled and randomly assigned to one of two groups: 1) Standard of Care; or 2) Biofeedback (standard medical care plus 10 sessions of biofeedback training).
Measures of pain, functional disability, quality of life, physiological arousal, and global treatment response will be collected pre- and post-intervention, as well as 3 and 6 months later.
Data collected will be used to determine how many participants will be needed for the full research study.
If biofeedback training is ultimately found to be a positive addition to standard medical treatment, this could lead to improved health outcomes for children with RAP.
This information also could result in greater treatment efficiency and reduced health care costs for families, insurance providers, and the hospital system.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 64108
- Children's Mercy Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A current diagnosis of eosinophilic duodenitis per biopsy.
- Ability to participate in the biofeedback training protocol.
- Transportation available to attend twice weekly visits to Children's Mercy Hospital (CMH).
Exclusion Criteria:
- Previous biofeedback training.
- Previous failure of medications used as standard of care in this study.
- Allergy to medications prescribed in this study.
- Co-morbid chronic illness requiring regular medical care.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: SMT
Standard Medication Treatment
|
10 sessions BART
|
Experimental: BART
Biofeedback-assisted Relaxation Training plus SMT
|
10 sessions BART
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Primary outcomes involve the feasibility of the method (e.g., compliance with daily diary, salivary cortisol collection)
Time Frame: Up to 6 months
|
Up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Functional disability rating scale at 6 weeks, 3 months, and 6 months
Time Frame: 6 weeks, 3 months, and 6 months
|
6 weeks, 3 months, and 6 months
|
Pain ratings on daily diary, at 6 weeks, 3 months, and 6 months
Time Frame: 6 weeks, 3 months, and 6 months
|
6 weeks, 3 months, and 6 months
|
Changes in salivary cortisol at 6 weeks, 3 months, and 6 months
Time Frame: 6 weeks, 3 months, and 6 months
|
6 weeks, 3 months, and 6 months
|
Changes in other psychosocial measures (e.g., Behavior Assessment System for Children (BASC), sleep survey, quality of life, etc.) at 6 weeks, 3 months, and 6 months
Time Frame: 6 weeks, 3 months, and 6 months
|
6 weeks, 3 months, and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jennifer V Schurman, Ph.D., Children's Mercy Hospital Kansas City
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2004
Primary Completion (Actual)
August 1, 2006
Study Completion (Actual)
August 1, 2006
Study Registration Dates
First Submitted
July 26, 2005
First Submitted That Met QC Criteria
July 26, 2005
First Posted (Estimate)
July 28, 2005
Study Record Updates
Last Update Posted (Estimate)
May 30, 2008
Last Update Submitted That Met QC Criteria
May 29, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00003103
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Pain
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaCompletedFunctional Gastrointestinal Disorders | Functional Abdominal Pain Syndrome | Abdominal Pain (AP)
-
Duke UniversityUnknown
-
Children's Mercy Hospital Kansas CityUniversity of ArizonaCompletedFunctional Abdominal Pain
-
University of WashingtonUniversity of North Carolina; MultiCare Mary Bridge Children's Hospital & Health...Completed
-
University of MichiganTerminatedFunctional Abdominal PainUnited States
-
University of BariClinica PEdiatrica Ospedale San Paolo Bari ItalyCompletedFunctional Abdominal PainItaly
-
National Center for Complementary and Integrative...CompletedRecurrent Abdominal PainUnited States
-
Jacques E. ChellyNational Institute on Drug Abuse (NIDA); Masimo CorporationRecruitingOpioid Use | Cancer Pain | Auriculotherapy | Pain, AbdominalUnited States
-
Michigan State UniversitySpectrum Health HospitalsWithdrawnFunctional Abdominal Pain SyndromeUnited States
-
Region Örebro CountyÖrebro University, SwedenActive, not recruitingFunctional Abdominal Pain | IBSSweden
Clinical Trials on Biofeedback-assisted relaxation training
-
Northwestern UniversityAmerican Pain Society; Rosalind Franklin University of Medicine and Science; Insulin...CompletedDiabetic Neuropathy, Painful
-
Eunice Kennedy Shriver National Institute of Child...UnknownCerebral PalsyUnited States
-
US Department of Veterans AffairsCompletedMigraine | Headache | Tension Headache | Stress Headache | Vascular HeadacheUnited States
-
Rehazentrum WilhelmshavenCompletedMultiple Sclerosis | FatigueGermany
-
East Tennessee State UniversityWithdrawnAnxiety | Biofeedback, Psychology
-
Eunice Kennedy Shriver National Institute of Child...Unknown
-
Far Eastern Memorial HospitalRecruitingStress Urinary Incontinence | Urethral Hypermobility | Intrinsic Sphincter DeficiencyTaiwan
-
Chimei Medical CenterTerminatedPanic DisorderTaiwan
-
Chimei Medical CenterNational Cheng Kung UniversityTerminatedPanic DisorderTaiwan
-
Istituto Auxologico ItalianoCompletedGeneralized Anxiety DisorderItaly